Filters
Also try searching for:
*YAV
on 16 Oct 2024
Novartis AG
2356308 · 21 Aug 2024
005
Class 005
Pharmaceutical Products
Préparations pharmaceutiques pour la prévention et le traitement du système nerveux central, à savoir les infections du système nerveux central, les maladies du cerveau, les troubles du mouvement du système nerveux central, les troubles de la motilité oculaire, les maladies de la moelle épinière; préparations pharmaceutiques pour la prévention et le traitement de maladies immunologiques, à savoir des maladies auto-immunes, des syndromes de déficit immunitaire; préparations pharmaceutiques pour la prévention et le traitement des maladies cardiovasculaires; préparations pharmaceutiques pour la prévention et le traitement du diabète; préparations pharmaceutiques pour la prévention et le traitement des troubles métaboliques, à savoir le diabète, l'obésité, l'hyperlipidémie, la résistance à l'insuline, le syndrome métabolique; anti-inflammatoires; préparations pharmaceutiques pour la prévention et le traitement des troubles du système respiratoire; préparations pharmaceutiques pour la prévention et le traitement des troubles du système musculo-squelettique, à savoir les maladies du tissu conjonctif, les maladies des os, les maladies de la colonne vertébrale, les maux de dos, les fractures, les entorses, les blessures du cartilage; préparations pharmaceutiques pour la prévention et le traitement des maladies génito-urinaires, à savoir les maladies urologiques, l'infertilité, les maladies sexuellement transmissibles, les inflammations pelviennes; préparations pharmaceutiques pour utilisation en dermatologie, à savoir pour la prévention et le traitement du psoriasis, de l'urticaire, de l'hidradénite suppurée, de la dermatite, des maladies affectant la pigmentation de la peau, des maladies sexuellement transmissibles; préparations pharmaceutiques utilisées en oncologie; préparations pharmaceutiques utilisées en hématologie, à savoir pour le traitement des troubles sanguins; préparations pharmaceutiques utilisées pour la transplantation de tissus et d'organes; préparations pharmaceutiques utilisées en ophtalmologie; préparations pharmaceutiques utilisées en gastroentérologie; préparations pharmaceutiques pour la prévention et le traitement des troubles et des maladies oculaires; anti-infectieux, antibactériens, antiviraux, antibiotiques, antifongiques systémiques et topiques.
Préparations pharmaceutiques pour la prévention et le traitement du sy...
on 02 Dec 2024
Camurus AB
2199281 · 27 Apr 2022
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for injection for the treatment of endocrine diseases and disorders; pharmaceutical preparations for injection for the treatment of tumours; pharmaceutical preparations for injection for the treatment of carcinoid tumours; pharmaceutical preparations for injection comprising peptides for hormonal treatment and tumour treatment; pharmaceutical preparations for injection for the treatment of neuroendocrine tumours; pharmaceutical preparations for injection for the treatment of gastro-enteropancreatic neuroendocrine tumours; pharmaceutical preparations for injection for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for injection for gastrointestinal bleeding disorders; pharmaceutical preparations for injection for the treatment of gastrointestinal bleeding disorders; pharmaceutical preparations for injection for the treatment of esophageal bleeding; pharmaceutical preparations for injection for metabolic disorders; pharmaceutical preparations for injection for the treatment of acromegaly; pharmaceutical preparations for injection for the treatment of polycystic liver disease; pharmaceutical preparations for injection for the treatment of respiratory diseases or syndrome; pharmaceutical preparations for injection for the treatment of respiratory distress syndrome; pharmaceutical preparations for injection for the treatment of acute respiratory distress syndrome; pharmaceutical preparations for injection for the treatment of disorders of the autonomic nervous system; pharmaceutical preparations for injection intended to block growth hormone; Pharmaceutical preparations for subcutaneous injection for the treatment of endocrine diseases and disorders; pharmaceutical preparations for subcutaneous injection for the treatment of tumours; pharmaceutical preparations for subcutaneous injection for the treatment of carcinoid tumours; pharmaceutical preparations for subcutaneous injection comprising peptides for hormonal treatment and tumour treatment; pharmaceutical preparations for subcutaneous injection for the treatment of neuroendocrine tumours; pharmaceutical preparations for subcutaneous injection for the treatment of gastro-enteropancreatic neuroendocrine tumours; pharmaceutical preparations for subcutaneous injection for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for subcutaneous injection for gastrointestinal bleeding disorders; pharmaceutical preparations for subcutaneous injection for the treatment of gastrointestinal bleeding disorders; pharmaceutical preparations for subcutaneous injection for the treatment of esophageal bleeding; pharmaceutical preparations for subcutaneous injection for metabolic disorders; pharmaceutical preparations for subcutaneous injection for the treatment of acromegaly; pharmaceutical preparations for subcutaneous injection for the treatment of polycystic liver disease; pharmaceutical preparations for subcutaneous injection for the treatment of respiratory diseases or syndrome; pharmaceutical preparations for subcutaneous injection for the treatment of respiratory distress syndrome; pharmaceutical preparations for subcutaneous injection for the treatment of acute respiratory distress syndrome; pharmaceutical preparations for subcutaneous injection for the treatment of disorders of the autonomic nervous system; pharmaceutical preparations for subcutaneous injection intended to block growth hormone; pharmaceutical preparations for the treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for the treatment of carcinoid tumours; pharmaceutical preparations comprising peptides for hormonal treatment and tumour treatment; pharmaceutical preparations for the treatment of neuroendocrine tumours; pharmaceutical preparations for the treatment of gastro-enteropancreatic neuroendocrine tumours; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for gastrointestinal bleeding disorders; pharmaceutical preparations for the treatment of gastrointestinal bleeding disorders; pharmaceutical preparations for the treatment of esophageal bleeding; pharmaceutical preparations for metabolic disorders; pharmaceutical preparations for the treatment of acromegaly; pharmaceutical preparations for the treatment of polycystic liver disease; pharmaceutical preparations for the treatment of respiratory diseases or syndrome; pharmaceutical preparations for the treatment of respiratory distress syndrome; pharmaceutical preparations for the treatment of acute respiratory distress syndrome; pharmaceutical preparations for the treatment of disorders of the autonomic nervous system; pharmaceutical preparations intended to block growth hormone
010
Class 010
Medical Instrument Products
Autoinjectors for administration of pharmaceuticals for the treatment of endocrine diseases and disorders; autoinjectors for administration of pharmaceuticals for the treatment of tumours; autoinjectors for administration of pharmaceuticals for the treatment of carcinoid tumours; autoinjectors for administration of pharmaceuticals comprising peptides for hormonal treatment and tumour treatment; autoinjectors for administration of pharmaceuticals for the treatment of neuroendocrine tumours; autoinjectors for administration of pharmaceuticals for the treatment of gastro-enteropancreatic neuroendocrine tumours; autoinjectors for administration of pharmaceuticals for the treatment of gastrointestinal diseases and disorders; autoinjectors for administration of pharmaceuticals for gastrointestinal bleeding disorders; autoinjectors for administration of pharmaceuticals for the treatment of gastrointestinal bleeding disorders; autoinjectors for administration of pharmaceuticals for the treatment of esophageal bleeding; autoinjectors for administration of pharmaceuticals for metabolic disorders; autoinjectors for administration of pharmaceuticals for the treatment of acromegaly; autoinjectors for administration of pharmaceuticals for the treatment of polycystic liver disease; autoinjectors for administration of pharmaceuticals for the treatment of respiratory diseases or syndrome; autoinjectors for administration of pharmaceuticals for the treatment of respiratory distress syndrome; autoinjectors for administration of pharmaceuticals for the treatment of acute respiratory distress syndrome; autoinjectors for administration of pharmaceuticals for the treatment of disorders of the autonomic nervous system; autoinjectors for administration of pharmaceuticals intended to block growth hormone; syringes for administration of pharmaceuticals for the treatment of endocrine diseases and disorders; syringes for administration of pharmaceuticals for the treatment of tumours; syringes for administration of pharmaceuticals for the treatment of carcinoid tumours; syringes for administration of pharmaceuticals comprising peptides for hormonal treatment and tumour treatment; syringes for administration of pharmaceuticals for the treatment of neuroendocrine tumours; syringes for administration of pharmaceuticals for the treatment of gastro-enteropancreatic neuroendocrine tumours; syringes for administration of pharmaceuticals for the treatment of gastrointestinal diseases and disorders; syringes for administration of pharmaceuticals for gastrointestinal bleeding disorders; syringes for administration of pharmaceuticals for the treatment of gastrointestinal bleeding disorders; syringes for administration of pharmaceuticals for the treatment of esophageal bleeding; syringes for administration of pharmaceuticals for metabolic disorders; syringes for administration of pharmaceuticals for the treatment of acromegaly; syringes for administration of pharmaceuticals for the treatment of polycystic liver disease; syringes for administration of pharmaceuticals for the treatment of respiratory diseases or syndrome; syringes for administration of pharmaceuticals for the treatment of respiratory distress syndrome; syringes for administration of pharmaceuticals for the treatment of acute respiratory distress syndrome; syringes for administration of pharmaceuticals for the treatment of disorders of the autonomic nervous system; syringes for administration of pharmaceuticals intended to block growth hormone; pens for administration of pharmaceuticals for the treatment of endocrine diseases and disorders; pens for administration of pharmaceuticals for the treatment of tumours; pens for administration of pharmaceuticals for the treatment of carcinoid tumours; pens for administration of pharmaceuticals comprising peptides for hormonal treatment and tumour treatment; pens for administration of pharmaceuticals for the treatment of neuroendocrine tumours; pens for administration of pharmaceuticals for the treatment of gastro-enteropancreatic neuroendocrine tumours; pens for administration of pharmaceuticals for the treatment of gastrointestinal diseases and disorders; pens for administration of pharmaceuticals for gastrointestinal bleeding disorders; pens for administration of pharmaceuticals for the treatment of gastrointestinal bleeding disorders; pens for administration of pharmaceuticals for the treatment of esophageal bleeding; pens for administration of pharmaceuticals for metabolic disorders; pens for administration of pharmaceuticals for the treatment of acromegaly; pens for administration of pharmaceuticals for the treatment of polycystic liver disease; pens for administration of pharmaceuticals for the treatment of respiratory diseases or syndrome; pens for administration of pharmaceuticals for the treatment of respiratory distress syndrome; pens for administration of pharmaceuticals for the treatment of acute respiratory distress syndrome; pens for administration of pharmaceuticals for the treatment of disorders of the autonomic nervous system; pens for administration of pharmaceuticals intended to block growth hormone; devices for subcutaneous administration of pharmaceuticals; syringes for subcutaneous administration of pharmaceuticals; syringes for parenteral administration of pharmaceuticals; syringes for injection of pharmaceutical depots; syringes for subcutaneous injection of pharmaceutical depot; syringes for parenteral injection of pharmaceutical depot; syringes for injection of injection fluids; syringes for injection of injection depot; syringes for injections; syringes for medical uses; pens for subcutaneous administration of pharmaceuticals; pens for parenteral administration of pharmaceuticals; pens for injection of pharmaceutical depots; pens for subcutaneous injection of pharmaceutical depot; pens for parenteral injection of pharmaceutical depot; pens for injection of injection fluids; pens for injection of injection depot; pens for injections; pens for medical uses
Pharmaceutical preparations for injection for the treatment of endocri...
on 11 Jan 2024
SHISHI NEWSHANG SPORTING GOODS CO. LTD.
2154664 · 12 Nov 2021
028
Class 028
Toys and Sporting Goods Products
Bladders of balls for games; strings for rackets; cricket bags; rackets for sports; shuttlecocks; rackets; tennis rackets; balls and bags adapted for rackets; chest expanders; grip tapes for rackets.
Bladders of balls for games; strings for rackets; cricket bags; racket...
on 31 May 2023
GLAXO GROUP LIMITED
2141444 · 12 Jul 2021
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), human papilloma virus, respiratory syncytial virus, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders and their symptoms; pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; pharmaceutical preparations for the treatment of immunologic diseases and disorders namely, autoimmune diseases and disorders; pharmaceutical preparations for the treatment of atherosclerosis; pharmaceutical preparations for the treatment of viral conditions namely human immunodeficiency virus (HIV), HPV, RSV, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; pharmaceutical preparations for the treatment and prevention of cardiovascular, cardiopulmonary, cardio-renal and renal diseases and disorders; pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis; pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain, bone pain and fatigue; pharmaceutical preparations for the treatment of blood-related diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, sepsis and infections in and of the blood; pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, sports injuries, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement and osteoarthritis; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and skin structure infections namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema and sexually transmitted diseases; pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely hypogonadism, testosterone/androgen disorders and estrogen disorders; pharmaceutical preparations for the treatment of gastrointestinal related diseases and disorders namely irritable bowel disorders and symptoms, digestive disorders and acid-related disorders; pharmaceutical preparations for the treatment of sexual dysfunction namely erectile dysfunction, male and female sexual dysfunction disorders namely arousal disorder, pain disorder, desire disorder and orgasm disorder; pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders; pharmaceutical preparations for the treatment of gynaecological diseases and disorders namely amenorrhoea, dysmenorrheal and infertility; pharmaceutical hormonal preparations namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, vasomotor/menopausal symptoms, endometriosis/uterine fibroids, Leiomyoma, endourology/stone, pre-eclampsia and pre-term labour; pharmaceutical preparations for the treatment of prostatitis, nephritis, cystitis, vaginitis, renal disease; pharmaceutical preparations for the treatment of premenstrual dysphoric disorder, premenstrual syndrome, male hypogonadism and hormonal disorders namely polycystic ovary syndrome; pharmaceutical preparations for the treatment of hepatological related diseases namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; pharmaceutical preparations for the treatment of alopecia and androgenic alopecia (male pattern baldness); pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; pharmaceutical preparations for the treatment of damaged skin and tissue namely bee stings, sunburn, rashes, sores, corns, calluses and acne; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of malaria; pharmaceutical preparations for the treatment of tuberculosis; allergy medications; vaccines namely prophylactic and therapeutic vaccines for humans; pharmaceutical preparations for the treatment of neurological diseases and disorders namely parkinsons disease, alzheimers disease, huntingtons disease, dementia, migraine, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory-related pain, fibromyalgia, stroke, multiple sclerosis, insomnia; pharmaceutical preparations for the treatment of central nervous system diseases and disorders namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, depression and anxiety and their related disorders namely schizophrenia and psychoses; pharmaceutical preparations for the treatment of muscular dystrophy.
Pharmaceutical preparations for use as anti-infectives; pharmaceutical...
on 10 Aug 2022
YAVASÇALAR TROY SAVUNMA SANAYI ANONIM SIRKETI
1974147 · 05 Jul 2019
013
Class 013
Firearm Products
Adjusting knobs for firearm sights; adjusting knobs for gun sights; aerial bombs; air guns; air pistol bullets; air pistols; air shot; ammonium nitrate explosives; ammunition; ammunition caissons; ammunition casings; ammunition for firearms; ammunition for small arms; anti-aircraft guns; armour-piercing projectiles; armour-piercing shells; artillery guns; automatic carbines; automatic firearm ammunition belts; automatic guns; automatic pistols; automatic revolvers; automatic rifles; bags specially adapted to hold rifles; bags specially made for ammunition; ballistic missiles; ballistic weapons; barrel reflectors for firearms; BB guns; bengal lights; black powder; blank cartridge shells; blank cartridges; blasting compounds; blasting compounds and explosives; blasting explosives; blasting gelatin; blasting paper; blasting powder; bodies of shell; bomb releasers; bombs; breeches of firearms; bullet and shell extractors; bullet casings; bullet extractors; bullets; butt plates for firearms; butt plates for pistols; butt plates for rifles; butt plates for shotguns; butts for small arms; cannons; carbines; cartridges for gunpowder; cartridges for guns; cartridges for machine guns; cartridges for pyrotechnic products; cartridges for rifles; cartridges for shotguns; case covers for firearms; cases for guns; cases for large size ammunition; cases for pistols; cases for rifles; chemical-based personal security sprays; component parts for machine guns; component parts for pistols; component parts for revolvers; component parts for rifles; component parts for shotguns; covers for firearms; covers for rifles; depth charges; detonators; dynamite; dynamites; explosive caps; explosive fuses; explosive mines; explosive powders; explosive shells; explosive torpedoes; explosives; field guns; firearm barrels; firearm breeches; firearms; fireworks; fireworks bodies; flare pistols; gas bombs; grenades; guided artillery projectiles; guided bombs; guided missiles; guided missiles and projectiles; guided mortar bombs; guided projectiles; gun and rifle cases; gun barrels; gun carriages; gun cartridges; gun cases; hand grenades; hand guns; heavy guns; holsters; liquid explosives; machine gun cartridges; machine guns; military rifles; missiles; mortar firearms; mortar shells; naval guns; noise suppressors for guns; noise-suppressors for guns; pistol cases; recoilless guns; rifle barrels; rifle cases; rifle covers; rifles; rocket launchers; rocket missiles; rockets; sea mines; sheaths for rifles; shotgun cartridges; shotguns; shoulder straps for weapons; sighting mirrors for guns and rifles; signal fires; small arms ammunition; smart mines; smart missiles; sprays for personal defence purposes; sprays for personal defense purposes; stun guns; tear gas weapons; tear-gas weapons; torpedoes; underwater mines; weapon cases for firearms; weapons in the form of gas bombs
Adjusting knobs for firearm sights; adjusting knobs for gun sights; ae...
on 23 Aug 2022
TRICHOME CANNABRANDS INC.
1965452 · 29 May 2019
003
Class 003
Cosmetics and Cleaning Products
Cosmetics; Makeup; Makeup removers; Beauty care cosmetics; Eye cream; Body creams; Massage creams; Massage oils; Skin care preparations; Body powders; Body oils; Bath soap; Moisturizing skin lotions; Body sprays used as personal deodorants and fragrances; Non-medicated bath salts; Exfoliating scrubs for the body; Bath oils; Bubble bath; Nail polish; Nail polish remover; Lip care preparations; Sun care preparations for cosmetic purposes; Sun block; Sun creams; Self-tanning preparations; After sun creams; Pre-shave and after-shave preparations; Body deodorants; Antiperspirants; Hair care preparations; Hair oils; Essential oils for cosmetic purposes; Essential oils for aromatherapy; Oils for perfumes and scents; Cannabis oil for cosmetic purposes; Essential oils for personal use.
005
Class 005
Pharmaceutical Products
Medicinal cannabis for the relief of nerve pain; Medicinal cannabis for the treatment of muscle spasms caused by multiple sclerosis; Medicinal cannabis for the relief of nausea caused by chemotherapy; Medicinal cannabis for temporary relief of seizures; Cannabis oil for the treatment of cancer; CBD oil for medical purposes; Topical anesthetics; Antibiotic cream; Anti-inflammatory ointments; Therapeutic medicated bath preparations; Herbal supplements for general health and well-being; Nutritional supplements for animal foodstuff; Pet food additives in the form of vitamins and minerals; Pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia; Sleeping pills; Tetrahydrocannabinol [THC] oil for medical purposes.
...
Class 009
Computer & Software Products & Electrical & Scientific Products
Sunglasses; Electronic newsletters; Downloadable electronic publications in the nature of magazines; Downloadable multimedia news weblogs.
Class 010
Medical Instrument Products
Cases fitted for medical instruments; Medical instruments bags; Vaporizers for medical purposes.
Class 016
Paper Goods and Printed Material
Magazines; Books.
Class 018
Leather Products (not including clothing)
All-purpose carrying bags; Cosmetic bags; Card cases; Pet clothing; Pet collars; Pet leashes.
Class 025
Clothing Products
Clothing, namely, shirts, pants, shorts, jackets, sweaters, and coats; Hats; Scarves; Shoes.
Class 029
Meats and Processed Food Products
Cannabis oil for food; Edible oils.
Class 030
Staple Food Products
Chocolate bars infused with cannabis; Brownies containing marijuana; Chocolate; Sugar confectionery; Beverage flavourings; Beverages made of coffee; Tea.
Class 031
Natural Agricultural Products
Live cannabis plants; Dog food; Pet food.
Class 032
Light Beverage Products
Non-alcoholic fruit-based beverages; Carbonated soft drinks; Sports drinks.
Class 033
Wines and Spirits Products
Alcoholic-based beverages; Alcoholic fruit beverages; Alcoholic tea-based beverages.
Class 034
Smoker's Products
Cannabis grinders; Cannabis oil for electronic cigarettes; Cannabis oil for oral vaporizers for smoking; Dried cannabis; Tetrahydrocannabinol [THC] oil for oral vaporizers for smoking; Tetrahydrocannabinol [THC] oil for electronic cigarette; Cannabidiol [CBD] oil for electronic cigarettes; Cannabidiol [CBD] oil for oral vaporizers for smoking; Smoking herb grinders; Hookahs; Herbs for smoking; Electronic smoking pipes; Cigarette cases.
Class 035
Advertising, Business & Retail Services
Online and retail sale of clothing; Online and retail sale of food; Online and retail sale of cannabis, cannabis related products, derivatives of cannabis and natural health products containing cannabis.
Class 039
Transportation & Storage Services
Merchandise packaging; Packaging of cannabis, cannabis related products, derivatives of cannabis and natural health products containing cannabis
Class 042
Computer & Software Services & Scientific Services
Providing a website with information about plants.
Class 044
Medical, Beauty & Agricultural Services
Providing information in the field of medical marijuana and cannabis; Cultivation of plants; Consultancy services relating to the cultivation of plants; Providing the breeding, growing, cultivation, harvesting and production of cannabis.
Class 045
Personal & Legal & Social Services
Online social networking services.
Cosmetics; Makeup; Makeup removers; Beauty care cosmetics; Eye cream; ...
on 15 Jul 2020
GLAXO GROUP LIMITED
1851142 · 04 Aug 2017
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for use as anti-infectives; Pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), human papilloma virus (HPV), respiratory syncytial virus (RSV), hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; Pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders and their symptoms; Pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; Pharmaceutical preparations for the treatment of immunologic diseases and disorders namely, autoimmune diseases and disorders; Pharmaceutical preparations for the treatment of atherosclerosis; Pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; Pharmaceutical preparations for the treatment and prevention of cardiovascular, cardiopulmonary, cardio-renal and renal diseases and disorders; Pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders; Pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis; Pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain, bone pain and fatigue; Pharmaceutical preparations for the treatment of blood-related diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, sepsis and infections in and of the blood; Pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, sports injuries, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement and osteoarthritis; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and skin structure infections namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema and sexually transmitted diseases; Pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely hypogonadism, testosterone/androgen disorders and estrogen disorders; Pharmaceutical preparations for the treatment of gastrointestinal related diseases and disorders namely irritable bowel disorders and symptoms, digestive disorders and acid-related disorders; Pharmaceutical preparations for the treatment of sexual dysfunction namely erectile dysfunction, male and female sexual dysfunction disorders namely arousal disorder, pain disorder, desire disorder and orgasm disorder; Pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders; Pharmaceutical preparations for the treatment of gynaecological diseases and disorders namely amenorrhoea, dysmenorrheal and infertility; Pharmaceutical hormonal preparations namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; Pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; Pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, vasomotor/menopausal symptoms, endometriosis/uterine fibroids, Leiomyoma, endourology/stone, pre-eclampsia and pre-term labour; Pharmaceutical preparations for the treatment of prostatitis, nephritis, cystitis, vaginitis, renal disease; Pharmaceutical preparations for the treatment of premenstrual dysphoric disorder, premenstrual syndrome, male hypogonadism and hormonal disorders namely polycystic ovary syndrome; Pharmaceutical preparations for the treatment of hepatological related diseases namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; Pharmaceutical preparations for the treatment of alopecia and androgenic alopecia (male pattern baldness); Pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; Pharmaceutical preparations for the treatment of damaged skin and tissue namely bee stings, sunburn, rashes, sores, corns, calluses and acne; Pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; Pharmaceutical preparations for the treatment of malaria; Pharmaceutical preparations for the treatment of tuberculosis; Allergy medications; Vaccines namely prophylactic and therapeutic vaccines for humans; Pharmaceutical preparations for the treatment of neurological diseases and disorders namely Parkinson's Disease, Alzheimer's Disease, Huntington's Disease, dementia, migraine, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory-related pain, fibromyalgia, stroke, multiple sclerosis, insomnia; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, depression and anxiety and their related disorders namely schizophrenia and psychoses; Pharmaceutical preparations for the treatment of muscular dystrophy
Pharmaceutical preparations for use as anti-infectives; Pharmaceutical...
on 03 Oct 2018
JOHNSON & JOHNSON
1718597 · 10 Mar 2015
005
Class 005
Pharmaceutical Products
Human pharmaceuticals for the prevention or treatment of auto-immune diseases, cardiovascular diseases, gastro-intestinal diseases, oncologic diseases, ophthalmic diseases, and respiratory diseases; pharmaceutical preparations for the prevention or treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; pharmaceutical preparations for the prevention or treatment of neurological diseases, namely Alzheimer's, Huntington's disease, and cerebral palsy; pharmaceutical preparations for the prevention or treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, and schizophrenia; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases, psoriasis; anti-viral medications; anti-inflammatory medications; anti-pain medications; and anti-infective medications
Human pharmaceuticals for the prevention or treatment of auto-immune d...
on 04 Jul 2018
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
1582190 · 14 Jun 2012
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for the treatment of central nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease; pharmaceutical preparations for the treatment of neurological diseases and disorders, namely brain injury, spinal cord injury, seizure disorders, Alzheimer's, Huntington's disease, cerebral palsy; pharmaceutical preparations for the treatment of genitourinary diseases, namely urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of gastrointestinal / diseases and disorders; pharmaceutical preparations for the treatment of musculoskeletal diseases and disorders, namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for the treatment of hypertension; pharmaceutical preparations for the treatment of erectile dysfunction; pharmaceutical preparations for the treatment of sexual dysfunction; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of migraines; pharmaceutical preparations for the treatment of pain, namely headaches, migraines, back pain, pain from burns, neuropathic pain; pharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases, namely inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of infectious diseases, namely respiratory infections, eye infections; pharmaceutical preparations for the treatment of immunological diseases and disorders, namely autoimmune diseases, immunologic deficiency syndromes, Acquired Immune Deficiency Syndrome (AIDS); pharmaceutical preparations for the treatment of viral diseases and disorders, namely herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); pharmaceutical preparations for the treatment of stroke; pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely mood disorders, anxiety disorders, panic disorders, cognitive disorders, schizophrenia, depression; pharmaceutical preparations for the treatment of substance abuse disorders, namely alcoholism and drug addiction; pharmaceutical preparations for the treatment of carpal tunnel syndrome; pharmaceutical preparations for the treatment of varicose veins; pharmaceutical preparations for the treatment of dental and oral diseases; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of yeast infections; pharmaceutical preparations for the treatment of prostate disorders; pharmaceutical preparations for the treatment of pulmonary disorders; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in ocular disorders; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of gynecological disorders, namely premenstrual syndrome, endometreosis, yeast infections, menstrual irregularities; pharmaceutical preparations, namely cholesterol preparations, namely preparations to lower cholesterol; pharmaceutical preparations namely smoking cessation preparations; pharmaceutical preparations namely tissue and skin repair preparations; pharmaceutical preparations namely acne medication; pharmaceutical preparations namely allergy medication; pharmaceutical preparations namely antacids; pharmaceutical preparations namely anthelmintics; pharmaceutical preparations namely antiarrhythmics; pharmaceutical preparations namely antibiotics; pharmaceutical preparations namely anticoagulants; pharmaceutical preparations namely anticonvulsants; pharmaceutical preparations namely antidepressants; pharmaceutical preparations namely antiemetics; pharmaceutical preparations namely antiflatulants; pharmaceutical preparations namely antihistamines; pharmaceutical preparations namely antihypertensives; pharmaceutical preparations namely anti-infectives; pharmaceutical preparations namely anti-inflammatories; pharmaceutical preparations namely antiparasitics; pharmaceutical preparations namely antibacterials; pharmaceutical preparations namely antifungals; pharmaceutical preparations namely antivirals; pharmaceutical preparations namely burn relief medication; pharmaceutical preparations namely calcium channel blockers; pharmaceutical preparations namely central nervous system depressants; pharmaceutical preparations namely central nervous system stimulants; pharmaceutical preparations namely cough treatment medication; pharmaceutical preparations namely diarrhea medication; pharmaceutical preparations namely gastrointestinal medication; pharmaceutical preparations namely glaucoma agents; pharmaceutical preparations namely hydrocortisone; pharmaceutical preparations namely hypnotic agents; pharmaceutical preparations namely sedatives
Pharmaceutical preparations for the treatment of cardiovascular diseas...
on 06 May 2015
JOHNSON & JOHNSON A LEGAL ENTITY
1234107 · 18 Oct 2004
005
Class 005
Pharmaceutical Products
010
Class 010
Medical Instrument Products
Pharmaceutical preparations, namely analgesics; medical apparatus and instruments for transdermal administration of analgesic preparations.
Pharmaceutical preparations, namely analgesics; medical apparatus and ...
Country
CA
Status
All
Registered
Pending
Abandoned
Other
Owners
Glaxo group limited (2)
Boehringer ingelheim international gmbh (1)
Camurus ab (1)
Johnson & johnson (1)
Johnson & johnson a legal entity (1)
Novartis ag (1)
Shishi newshang sporting goods co. ltd. (1)
Trichome cannabrands inc.. (1)
Yavasçalar troy savunma sanayi anonim sirketi (1)
Categories
Class 5 (8)
Class 10 (3)
Class 3 (1)
Class 9 (1)
Class 13 (1)
Class 16 (1)
Class 18 (1)
Class 25 (1)
Class 28 (1)
Class 29 (1)
Class 30 (1)
Class 31 (1)
Class 32 (1)
Class 33 (1)
Class 34 (1)
Class 35 (1)
Class 39 (1)
Class 42 (1)
Class 44 (1)
Class 45 (1)
Correspondents
Borden ladner gervais llp (2)
Gowling wlg (canada) llp (2)
Marks & clerk (1)
Mccarthy tetrault llp (1)
Neomark ltd. (1)
Paul lomic (1)
Image Search
Drag and drop or upload to search any image
End of search results
Page 1 of 1